CIBC World Markets’s Tarsus Pharmaceuticals TARS Stock Holding History

CIBC World Markets’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$212K	Buy	+2,591	New	+$193K	﹤0.01%	1100
2025 Q2	–	Sell	-8,260	Closed	-$424K	–	1902
2025 Q1	$424K	Buy	+8,260	New	+$408K	﹤0.01%	1084
2024 Q2	–	Sell	-150,000	Closed	-$5.45M	–	796
2024 Q1	$5.45M	Buy	+150,000	New	+$4.41M	0.04%	304
2023 Q4	–	Sell	-50,000	Closed	-$889K	–	770
2023 Q3	$889K	Hold	50,000	–	–	0.01%	495
2023 Q2	$904K	Buy	+50,000	New	+$795K	0.01%	558

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

CIBC World Markets's TARS Position: Q4 2025 in Review

CIBC World Markets opened a new position in Tarsus Pharmaceuticals (TARS) in Q4 2025: 2,591 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #1100 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in TARS as recently as Q1 2025.

CIBC World Markets first reported a position in TARS in Q2 2023 and has held it in 5 quarters since. The position peaked at $5.45M in Q1 2024. 246 funds tracked by Wall St. Rank hold TARS as of Q4 2025.

CIBC World Markets held 2,591 shares of Tarsus Pharmaceuticals worth $212K as of Q4 2025.
Tarsus Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
Tarsus Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1100 holding.
CIBC World Markets first reported a position in Tarsus Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
CIBC World Markets's Tarsus Pharmaceuticals position peaked at $5.45M in Q1 2024.
246 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.